Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT06444958
Other study ID # KHRC2024/050
Secondary ID
Status Completed
Phase
First received
Last updated
Start date January 1, 2023
Est. completion date December 15, 2023

Study information

Verified date May 2024
Source Kalkaal Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This retrospective observational study aimed to investigate the patterns of morbidity and mortality among children under 5 years of age in the population served by Kalkaal Hospital. Researchers analyzed 2023 data from the hospital's electronic medical records and administrative databases to identify the most common pediatric diagnoses and causes of illness and death in this community.


Description:

This study investigated the patterns of morbidity and mortality among children under 5 years of age in the population served by Kalkaal Hospital. The specific objectives were to: Identify the most common diagnoses and causes of illness and death in the under-5 population presenting to Kalkaal Hospital. Analyze demographic factors (e.g. age, sex) associated with certain disease profiles and health outcomes. Evaluate treatment practices, health service utilization, and mortality rates for the key pediatric health issues identified. Provide a comprehensive epidemiological assessment of the burden of childhood illness and mortality in this local community. Methods: This was a retrospective, observational study that analyzed 2023 data from the electronic medical records and administrative databases of Kalkaal Hospital. The researchers extracted and analyzed the following data: Outpatient department records: Diagnoses, treatments, patient demographics Inpatient admission records: Admission diagnoses, treatments, patient outcomes (discharged, transferred, died) Mortality records: Causes of death for pediatric patients The data was cleaned, coded, and analyzed using statistical software. Descriptive statistics were calculated to characterize the morbidity and mortality patterns. Regression analyses were conducted to identify demographic and clinical factors associated with key health outcomes.


Recruitment information / eligibility

Status Completed
Enrollment 1675
Est. completion date December 15, 2023
Est. primary completion date December 15, 2023
Accepts healthy volunteers
Gender All
Age group 0 Months to 59 Months
Eligibility Inclusion Criteria: 1. Children aged 0-59 months who were admitted to Kalkaal Hospital during the specified study period. 2. Medical records with complete and adequate information regarding age, gender, presenting symptoms, and diagnoses. - Exclusion Criteria: 1. Children outside the age range of 0-59 months. 2. Medical records with missing or incomplete information necessary for the analysis. 3. Children admitted to Kalkaal Hospital for reasons unrelated to the study objectives (adult patients, non-pediatric cases).

Study Design


Related Conditions & MeSH terms


Intervention

Diagnostic Test:
observational study without any intervention component.
extracting and analyzing the following data: Outpatient department records: Diagnoses, treatments, patient demographics Inpatient admission records: Admission diagnoses, treatments, patient outcomes (discharged, transferred, died) Mortality records: Causes of death for pediatric patients

Locations

Country Name City State
Somalia Kalkaal Hospital Mogadishu Banadir

Sponsors (1)

Lead Sponsor Collaborator
Kalkaal Hospital

Country where clinical trial is conducted

Somalia, 

Outcome

Type Measure Description Time frame Safety issue
Primary Incidence Rate of Morbidities: Incidence rates of various morbidities among children presenting to the outpatient department and inpatient wards. This outcome measure will calculate the incidence rates of various morbidities among children under 18 years of age who presented to the Kalkaal Hospital outpatient department or were admitted to the inpatient wards during the 5-year study period (2018-2022). The incidence rates will be reported for the top 10 most common morbidities observed in the study population. JANUARY-DECEMBER 2023
Primary Mortality Rate by Age Group: Mortality rates and associated risk factors across different age groups of children under 18 (under 28 days, 29-365 days, 1-5 years). This outcome measure will determine the mortality rates among children under 18 years of age treated at Kalkaal Hospital, stratified by the following age groups: under 28 days, 29-365 days, and 1-5 years. The analysis will also identify risk factors associated with mortality in each age group. JANUARY-DECEMBER 2023
Primary Average Length of Hospital Stay: Median hospital stay duration for children under 18 years old. This outcome measure will calculate the median length of hospital stay for children under 18 years old who were admitted to the Kalkaal Hospital inpatient wards during the study period. The average length of stay will be reported overall, as well as by primary diagnosis categories. JANUARY-DECEMBER 2023
See also
  Status Clinical Trial Phase
Completed NCT03104946 - To Research the Relation Between Neonatal Morbidities and Poor Outcome in Preterm Infants N/A
Recruiting NCT05397678 - Trial to Compare BCG-Bulgaria and BCG-Denmark Phase 4
Completed NCT04383925 - Trial to Compare Two Strains of BCG Phase 4
Active, not recruiting NCT04634019 - Financially-Incentives to Improve Provider Compliance N/A
Completed NCT04778735 - Investigation of Mortality, Morbidity and Risk Factors After Pediatric Liver Transplantation N/A
Completed NCT03181178 - Effect of a Complementary Food Supplement on Growth and Morbidity of Ghanaian Infants N/A